Celebrating 20 Years of IP Excellence

Weekly Patent News

Natco withdraws compulsory license, signs agreement with Eli Lilly for Barcitinib; Patent Office notifies extension of timelines and more

In this week’s patent news: Patent Office notifies Supreme Court’s order on Extensions of Timelines; Patent office announces JPO/IPR Training Course FY 2021; BananaIP and NASSCOM to organize a Master Class on IP; Panacea Biotec accuses Sanofi of patent infringement, files suit; Natco and Eli Lilly sign patent license agreement for production of Barcitinib; NATCO and Eli Lilly sign patent license agreement for production of Barcitinib; India and South Africa propose three-year patent waiver. Patent Office notifies Supreme Court’s…

Read more

India and foreign patent news

Innovate, Patent, Produce and Prosper says PM, Natco Pharma faces patent infringement law suit and more

In this week’s Patent & Design News - “Innovate, Patent, Produce and Prosper,” says PM Narendra Modi; 12th edition of GIPC to be held in New Delhi, this week; IPO issues notification containing list of withdrawn patent applications; Taiho Pharmaceutical files patent infringement lawsuit against Natco Pharma; Eli Lilly wins lawsuit instituted against Apotex Inc. and other news updates. India Patent News 12th edition of GIPC to be held in New Delhi, this week The 12th edition of the…

Read more

Featured image reads patents imprinted on a surface made of iron. The post related to patents. To read the post click here.

Patent Infringement Claim on Cancer Treatment Drug

  “You win some and you lose some”, this is a phrase all too familiar to most people and more specifically to the market of pharmaceuticals. It is perhaps this phrase that most pharmaceutical companies live by during their existence! Patent infringement, claim invalidation, compulsory license and Generic companies are the most clichéd words that one comes across, whenever there is a mention of pharmaceutical patents. Eli Lilly (a cancer treatment drug) happens to be one such entity that has “been…

Read more